American Vietnamese Biotech Incorporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was VND 45,940.57 million compared to VND 42,933.48 million a year ago. Net income was VND 1,551.8 million compared to VND 3,385.1 million a year ago.

Basic earnings per share from continuing operations was VND 12 compared to VND 26 a year ago.